Moreover, it uses surface nectins to selectively penetrate tumor cells and proliferate within by using disrupted oncogenic and anti-viral pathways such as protein kinase R (PKR) and type I interferon (IFN) pathways [53]. The gene discussed is EIF2AK2; the disease is neoplasm.